DISCLOSURE: Current Engagements

DISCLOSURE: Current Engagements2022-05-04T07:40:45+00:00

Normax current engagements:

Stakeholders

  • SINTEF Strategic R&D Partner
  • Strategic Technology Vendors and Partners; AFRY, Cytiva, Emtunga, IQVIA, Merck, Syntegon, Watson-Marlow, WSP
  • mRNA UCV Consortium by NORMAX (ECAM Vaccines Limited)
  • Private Investors

Support by Norwegian Government Organizations

Pharmaceutical Industry Membership

NOT AN OFFER TO INVEST.
SEE RED HERRING DISCLAIMER.

Our Purpose. Our Process. Our Results.
Go to Top